Cargando…

Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - a double-blind, placebo-controlled study

BACKGROUND: Pancreatic exocrine insufficiency (PEI) results in maldigestion, leading to abdominal pain, steatorrhoea, malnutrition and weight loss. AIM: To assess the efficacy and safety of pancreatin (Creon 40000 MMS) in treating PEI due to chronic pancreatitis (CP). METHODS: This was a 1-week, dou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thorat, V, Reddy, N, Bhatia, S, Bapaye, A, Rajkumar, J S, Kini, D D, Kalla, M M, Ramesh, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Randomised Clinical Trials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528066/ https://www.ncbi.nlm.nih.gov/pubmed/22762290 http://dx.doi.org/10.1111/j.1365-2036.2012.05202.x

Ejemplares similares

Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension
por: Seiler, C M, et al.
Publicado: (2013)

Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS
por: Maev, Igor V., et al.
Publicado: (2020)

Comment on: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”
por: Petersen, Karl-Uwe
Publicado: (2021)

Kreon(®) (Creon(®)) vs. Lipancrea(®): In Vitro Comparison of Two Encapsulated Pancreatin Preparations
por: Hartmann, Sven, et al.
Publicado: (2022)

Author’s Reply to Petersen: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”
por: Maev, Igor V., et al.
Publicado: (2021)

Pancreatic Exocrine Insufficiency in Pancreatic Cancer
por: Vujasinovic, Miroslav, et al.
Publicado: (2017)

Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome
por: Baiazid, Latifa, et al.
Publicado: (2022)

Implementing a home-based virtual hypertension programme—a pilot feasibility study
por: Gupta, Aditi, et al.
Publicado: (2022)

Challenges in the management of pancreatic exocrine insufficiency
por: Shandro, Benjamin Myles, et al.
Publicado: (2018)

State of the Art in Exocrine Pancreatic Insufficiency
por: Diéguez-Castillo, Carmelo, et al.
Publicado: (2020)

Nivolumab-Induced Exocrine Pancreatic Insufficiency
por: Sweep, Boudewijn, et al.
Publicado: (2021)

Congenital etiologies of exocrine pancreatic insufficiency
por: Scheers, Isabelle, et al.
Publicado: (2022)

Nutrition in children with exocrine pancreatic insufficiency
por: Zheng, Yuhua, et al.
Publicado: (2023)

A randomised controlled trial of Lichtenstein repair with Desarda repair in the management of inguinal hernias
por: Jain, Sudhir Kumar, et al.
Publicado: (2021)

Untargeted Metabolomics for the Diagnosis of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis
por: Díaz, Caridad, et al.
Publicado: (2021)

Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer
por: Roeyen, G., et al.
Publicado: (2022)

Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis
por: Kunovský, Lumír, et al.
Publicado: (2021)

Pancreatic Exocrine Insufficiency after Bariatric Surgery
por: Vujasinovic, Miroslav, et al.
Publicado: (2017)

Less common etiologies of exocrine pancreatic insufficiency
por: Singh, Vikesh K, et al.
Publicado: (2017)

Exocrine pancreatic insufficiency: prevalence, diagnosis, and management
por: Capurso, Gabriele, et al.
Publicado: (2019)

Update on the diagnosis and management of exocrine pancreatic insufficiency
por: Perbtani, Yaseen, et al.
Publicado: (2019)

Ultrasonographic Findings of Exocrine Pancreatic Insufficiency in Dogs
por: Pelligra, Tina, et al.
Publicado: (2022)

Optimizing management of patients with pancreatic exocrine insufficiency
por: Arvanitakis, Marianna, et al.
Publicado: (2023)

Exocrine Pancreatic Insufficiency in Children – Challenges in Management
por: Sankararaman, Senthilkumar, et al.
Publicado: (2023)

Practical guide to exocrine pancreatic insufficiency – Breaking the myths
por: Struyvenberg, Maarten R., et al.
Publicado: (2017)

Bruising as the first sign of exocrine pancreatic insufficiency in infancy
por: Szabo, Csilla Enikő, et al.
Publicado: (2019)

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
por: Kiriukova, Mariia, et al.
Publicado: (2020)

Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis
por: Krishnamurty, Devi Mukkai, et al.
Publicado: (2009)

Is pancreatic exocrine insufficiency in celiac disease related to structural alterations in pancreatic parenchyma?
por: Rana, Surinder S., et al.
Publicado: (2016)

Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: Systematic Review and Meta-Analysis
por: Huang, Wei, et al.
Publicado: (2019)

Pancreatic Exocrine Insufficiency in Intraductal Papillary Mucinous Carcinoma Presenting with Leg Edema Treated with Pancreatic Exocrine Replacement Therapy
por: Tanaka, Emi, et al.
Publicado: (2021)

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study
por: Emmanuel, A V, et al.
Publicado: (2012)

Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS
por: Cremonini, F, et al.
Publicado: (2012)

Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1
por: Palmer, M, et al.
Publicado: (2012)

Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
por: Ashida, K., et al.
Publicado: (2015)

Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis
por: Rutgeerts, P., et al.
Publicado: (2015)

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects
por: Jenkins, H, et al.
Publicado: (2015)

Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
por: Ashida, K., et al.
Publicado: (2015)

Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis
por: Horvath, A., et al.
Publicado: (2016)

Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy
por: Shaheen, N. J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9p1u5sjd77khr0hv393ltijic6